• Allergan mauled by investors in public letter pharmafile
    June 07, 2018
    Last week, Allergan announced that a strategic review of its operations had led to a decision to divest its women’s health and infectious diseases unit – in doing so it hoped that investors would respond well to a leaner business.
PharmaSources Customer Service